MetLife Stock Forecast
NYSE: METFinanceLife InsuranceUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
MET analyst consensus
Consensus (18 analysts)
buy
Avg. price target
$107.19+9.01%
- Strong buy 5
- Buy 8
- Hold 4
- Sell 0
- Strong sell 1
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 18 Wall Street analysts covering MetLife (2026-10-09), 13 rate the stock a buy or strong buy, 4 rate it a hold and 1 rate it a sell or strong sell, for a consensus rating of "buy". The average 12-month price target is $107.19, with a high estimate of $119.00 and a low estimate of $84.00. The average target implies upside of 9.0% from the current price of $98.33.
The spread between the highest and lowest targets is 41.7%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for MET.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 5 | 28% |
| Buy | 8 | 44% |
| Hold | 4 | 22% |
| Sell | 0 | 0% |
| Strong sell | 1 | 6% |
Ratings as of 2026-10-09.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $84.00 | -14.57% |
| Average target | $107.19 | +9.01% |
| High target | $119.00 | +21.02% |